CA1 Antibody
Purified Mouse Monoclonal Antibody
- SPECIFICATION
- CITATIONS: 1
- PROTOCOLS
- BACKGROUND
Application
| WB, E |
---|---|
Primary Accession | P00915 |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Clone Names | 9D6D7 |
Isotype | IgG1 |
Calculated MW | 28870 Da |
Description | CA1: carbonic anhydrase I. Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA1 is closely linked to CA2 and CA3 genes on chromosome 8, and it encodes a cytosolic protein which is found at the highest level in erythrocytes. Transcript variants of CA1 utilizing alternative polyA_sites have been described in literature. |
Immunogen | Purified recombinant fragment of CA1 (aa25-90) expressed in E. Coli. |
Formulation | Ascitic fluid containing 0.03% sodium azide. |
Gene ID | 759 |
---|---|
Other Names | Carbonic anhydrase 1, 4.2.1.1, Carbonate dehydratase I, Carbonic anhydrase B, CAB, Carbonic anhydrase I, CA-I, CA1 |
Dilution | WB~~1/500 - 1/2000 IHC~~1:200~~1000 |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | CA1 Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | CA1 |
---|---|
Function | Catalyzes the reversible hydration of carbon dioxide (PubMed:10550681, PubMed:18618712, PubMed:16807956, PubMed:16686544, PubMed:17127057, PubMed:19186056, PubMed:19206230, PubMed:16506782, PubMed:17314045, PubMed:17407288). Can hydrate cyanamide to urea (PubMed:10550681). |
Cellular Location | Cytoplasm {ECO:0000250|UniProtKB:B0BNN3}. |
Provided below are standard protocols that you may find useful for product applications.
References
1. Res Exp Med (Berl). 1998 Dec;198(4):175-85. 2. Drugs Exp Clin Res. 2001;27(2):53-60.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.